Acadia Healthcare (ACHC) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- $0.38
- EPS estimate
- $0.35
- EPS surprise
- +9.73%
- Revenue surprise
- +2.56%
- Revenue
- $865.8M
- Revenue estimate
- $844.2M
- Reported
- Jul 28, 2026
Acadia Healthcare reported Q2 2026 results on July 28, 2026. Earnings per share were $0.38, beating the $0.35 estimate by 9.73%. Revenue of $865.8 million came in 2.56% above the $844.2 million estimate. Against Q2 2025, though, EPS fell about 54% from $0.83, and revenue was slightly lower than the $869.2 million reported then.
Earnings have dropped from earlier levels. Annual EPS was $3.01 in 2022, $3.43 in 2023 and $3.30 in 2024, then fell about 39% to $2.02 in 2025. Q4 2025 earned only $0.07 per share, the lowest quarter in the table, and the first half of 2026 totaled $0.75, against $1.23 a year earlier. Revenue moved the other way, rising each year from $2.61 billion in 2022 to $3.31 billion in 2025. Before 2025, quarterly EPS held between $0.67 and $0.92. Acadia Healthcare beat the EPS estimate in 17 of the last 20 quarters; the misses were Q3 2021, Q4 2022 and Q4 2024.
Q3 results came out between October 28 and November 5 in each of the past five years. That points to late October or early November 2026 for the next report, which will show whether EPS holds near its first-half 2026 level.
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Jul 28, 2026 | $0.35 | $0.38 | +9.73% | $865.8M | SEC |
| Q1 2026 | Apr 29, 2026 | $0.26 | $0.37 | +39.68% | $828.8M | SEC |
| Q4 2025 | Feb 25, 2026 | $0.01 | $0.07 | +686.52% | $821.5M | SEC |
| Q3 2025 | Nov 5, 2025 | $0.66 | $0.72 | +9.14% | $851.6M | SEC |
| Q2 2025 | Aug 5, 2025 | $0.69 | $0.83 | +19.46% | $869.2M | SEC |
| Q1 2025 | May 12, 2025 | $0.36 | $0.40 | +12.08% | $770.5M | SEC |
| Q4 2024 | Feb 27, 2025 | $0.71 | $0.64 | −10.44% | $774.2M | SEC |
| Q3 2024 | Oct 30, 2024 | $0.90 | $0.91 | +1.18% | $815.6M | SEC |
| Q2 2024 | Jul 31, 2024 | $0.88 | $0.91 | +3.85% | $796.0M | SEC |
| Q1 2024 | May 1, 2024 | $0.80 | $0.84 | +5.41% | $768.1M | SEC |
| Q4 2023 | Feb 27, 2024 | $0.79 | $0.85 | +7.24% | $742.8M | SEC |
| Q3 2023 | Nov 2, 2023 | $0.89 | $0.91 | +2.03% | $750.3M | SEC |
| Q2 2023 | Jul 27, 2023 | $0.86 | $0.92 | +7.28% | $731.3M | SEC |
| Q1 2023 | Apr 26, 2023 | $0.71 | $0.75 | +5.69% | $704.3M | SEC |
| Q4 2022 | Feb 27, 2023 | $0.75 | $0.70 | −6.59% | $675.3M | SEC |
| Q3 2022 | Oct 31, 2022 | $0.79 | $0.80 | +1.77% | $666.7M | — |
| Q2 2022 | Jul 27, 2022 | $0.78 | $0.84 | +7.97% | $651.7M | — |
| Q1 2022 | May 3, 2022 | $0.64 | $0.67 | +5.43% | $616.7M | — |
| Q4 2021 | Feb 28, 2022 | $0.68 | $0.81 | +18.58% | $593.5M | — |
| Q3 2021 | Oct 28, 2021 | $0.72 | $0.72 | −0.58% | $587.6M | — |
Quarterly revenue
Frequently asked questions
When did Acadia Healthcare (ACHC) last report earnings?
Acadia Healthcare last reported on Jul 28, 2026, covering fiscal Q2 2026.
Did ACHC beat earnings estimates?
Yes. Acadia Healthcare reported EPS of $0.38 for Q2 2026 against a $0.35 estimate — a 9.73% beat.
How much revenue did ACHC report last quarter?
Acadia Healthcare reported $865.8M in revenue for Q2 2026, against a consensus estimate of $844.2M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.